Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Infectious & Toxicology
Filter     Order     Display # 
Date Item Title Hits
01 Sep 2010 Lytix Biopharma AS Announces Approval by Hungarian Authorities and Ethics Committee to Start Phase IIa Clinical Trial with LytixarTM (LTX-109) in Gram Positive Skin Infections 4
01 Sep 2010 Inhibitex Successfully Completes Phase 1a Trial of INX-189 4
01 Sep 2010 Functional Technologies Reports Positive Results of Novel Malaria Treatment Trials 4
31 Aug 2010 BTG plc (BGC.L) Signs $16.6 Mln Deal To Sell Nycomed's Antivenom Drugs 4
31 Aug 2010 Achaogen Awarded Contract Worth up to $64 Million by Biomedical Advanced Research and Development Authority (BARDA) for the Development of ACHN-490 4
30 Aug 2010 Two Thirds of Study Volunteers Respond to First-Ever "Re-Vaccination" of Vacc-4x, Bionor Pharma's Peptide-Based Therapeutic HIV-Vaccine 5
30 Aug 2010 MedImmune receives complete response letter on motavizumab 5
26 Aug 2010 FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra Vaccine to Infants and Toddlers 5
26 Aug 2010 The Fourth Product Candidate Containing Antigenics' QS-21 In Phase 3 Clinical Development 4
26 Aug 2010 BioAlliance Pharma: Acyclovir Lauriad: US registration file submission planned end-2011 5
25 Aug 2010 ZymoGenetics Announces Completion of Enrollment in Phase 2b Clinical Trial with PEG-Interferon lambda in Hepatitis C 5
24 Aug 2010 AVI BioPharma Announces Positive Results Against Human Pandemic H1N1 Influenza Virus in Preclinical Studies of AVI-7100 6
23 Aug 2010 Nature Medicine Publishes AVI BioPharma Preclinical Studies Demonstrating Post-Exposure Efficacy of PMOplus(TM) Oligomers Against Ebola and Marburg Viruses 12
19 Aug 2010 Optimer Pharmaceuticals' Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency 7
17 Aug 2010 BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine 10
17 Aug 2010 Memorandum of Understandings for UMN Pharma's Cell Culture Based Influenza Vaccine Programas in Japan 7
16 Aug 2010 BioCryst's Partner Green Cross Receives Marketing & Manufacturing Approval for Peramivir in South Korea 19
16 Aug 2010 NanoViricides Reports that its Drug Candidates Demonstrated Significant Inhibition of Herpes Virus Infection 12
12 Aug 2010 Novavax Reports Positive Results from Pre-Clinical Safety Study of Respiratory Syncytial Virus (RSV) Vaccine Candidate 9
12 Aug 2010 PSI-7977 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 15
11 Aug 2010 Emergent BioSolutions and Temasek Life Sciences Ventures Establish Joint Venture to Develop Broad Spectrum Pandemic Flu Vaccine and Therapeutic 21
11 Aug 2010 Crucell and Harvard (BIDMC) Join Forces with IAVI to Advance AdVac(R)-based AIDS Vaccine 9
10 Aug 2010 Nabi Biopharmaceuticals Completes Third PentaStaph(TM) Milestone 18
10 Aug 2010 Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment 17
10 Aug 2010 Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia 11
10 Aug 2010 FDA Approves Longer Use of Valcyte for Adult Kidney Transplant Patients at High Risk of Developing Cytomegalovirus (CMV) Disease 17
04 Aug 2010 TapImmune Signs Research and Technology License Option Agreement for Smallpox Vaccine 11
04 Aug 2010 Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax 12
04 Aug 2010 In Pivotal Phase III Studies, Merck's Investigational Medicine Boceprevir Helped Majority of Patients with Chronic Hepatitis C Genotype 1 Infection Achieve Sustained Virologic Response, the Primary Endpoint of the Studies 14
03 Aug 2010 Telormedix and Swiss TPH Institute Sign Malaria and Buruli Ulcer Collaboration 15
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 30 of 2112

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Order Now

Recommended Report

R&D Drug Pipeline Database
Order Now

Subscribe La Merie Biologics